Medco Research Extends Research
- Share via
Medco Research Inc. of Los Angeles secured from the University of Virginia Alumni Patents Foundation an extension of its exclusive right to research, develop and market Adenocard for $200,000, according to a Securities and Exchange Commission filing.
Under the agreement, Medco has until March, 1992, to obtain Federal Drug Administration approval for Adenocard, an injectable acute treatment for supraventricular tachycardia.
Medco manufactures pharmaceuticals and medical devices.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
